论文部分内容阅读
目前,病人接受化疗后带来的脱发仍是一个令人烦恼的问题。治疗使许多病人感到极度心烦意乱,其中一些病人不愿意开始治疗,而其他一些病人则拒绝反复用药治疗。研究人员现在小鼠中进行的基因疗法研究的结果已证实可在分子水平上逆转脱发,该发现为将来在人类中进行的深入研究开辟了道路。据研究人员报道,约85％的接受烷基化类药物、taxanes、蒽环类(anthracyclines)或鬼臼乙叉甙(etoposide)治疗的病人可发生脱发,这是因为化疗药物可靶向快速生长的毛囊细胞。病人大
At present, the patient’s hair loss after chemotherapy is still a troublesome question. Many patients are extremely upset by the treatment, some of whom are reluctant to start treatment, while others refuse repeated treatment. Researchers Now that the results of gene therapy studies conducted in mice have demonstrated reversal of hair loss at the molecular level, this finding opens the way for in-depth research in the future. Researchers report that about 85% of patients treated with alkylating drugs, taxanes, anthracyclines, or etoposide can develop hair loss because chemotherapy drugs target rapid growth Hair follicle cells. The patient is big